Selection of developmentally competent immature equine oocytes with brilliant cresyl blue stain prior to in vitro maturation with equine growth hormone

Gabriel R. Pereira, Pedro L. Lorenzo, Gustavo F. Carneiro, Sylvie Bilodeau-Goeseels, John P. Kastelic, Alejandro Esteller-Vico, Manel Lopez-Bejar, Irwin Liu

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Immature oocytes synthesize a variety of proteins that include the enzyme glucose-6-phosphate dehydrogenase (G6PDH). Brilliant cresyl blue (BCB) is a vital blue dye that assesses intracellular activity of G6PDH, an indirect measure of oocyte maturation. The objective was to evaluate the BCB test as a criterion to assess developmental competence of equine oocytes and to determine if equine growth hormone (eGH) enhanced in vitro maturation (IVM) of equine oocyte. Cumulus-oocytes complexes (COCs) were recovered by aspirating follicles <30 mm in diameter from abattoir-derived ovaries and were evaluated morphologically. Thereafter, COCs were exposed to BCB (26 μM) for 90 min at 39°C and selected based on the colour of their cytoplasm (BCB positive/BCB+ or BCB negative/BCB-). The COCs were allocated as follows: (a) IVM medium; (b) eGH group; (c) BCB-/IVM; (d) BCB+/IVM; (e) BCB-/eGH; and (f) BCB+/eGH. Then, COCs were cultured in vitro for 30 h, at 39°C in a 5%CO2 humidified air atmosphere. Cumulus-free oocytes were incubated in 10 μg/ml of bis-benzamide for 20 min at 39°C and nuclear maturation was evaluated with epifluorescence microscopy. Of the 39 COCs selected morphologically and subjected to BCB staining, 18/39 (46.2%) were classified as BCB+ and 21/39 (53.8%) as BCB- (P > 0.05). Maturation was not affected significantly by BCB classification, but the maturation rate was higher for oocytes that had been exposed to exogenous eGH versus controls (16/28, 57.1% versus 8/26, 30.8%, P < 0.05). In the present study, the BCB test was not useful for predicting competent equine oocytes prior to IVM. However, eGH enhanced equine oocyte maturation in vitro.

Original languageEnglish (US)
Pages (from-to)500-504
Number of pages5
JournalZygote
Volume22
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

Growth Hormone
Horses
Oocytes
Coloring Agents
In Vitro Oocyte Maturation Techniques
Glucosephosphate Dehydrogenase
In Vitro Techniques
Brilliant Cresyl Blue
Mental Competency
Enzymes
Proteins

Keywords

  • Brilliant cresyl blue
  • Equine growth hormone
  • Horse
  • In vitro maturation
  • Oocyte competence

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

Selection of developmentally competent immature equine oocytes with brilliant cresyl blue stain prior to in vitro maturation with equine growth hormone. / Pereira, Gabriel R.; Lorenzo, Pedro L.; Carneiro, Gustavo F.; Bilodeau-Goeseels, Sylvie; Kastelic, John P.; Esteller-Vico, Alejandro; Lopez-Bejar, Manel; Liu, Irwin.

In: Zygote, Vol. 22, No. 4, 01.01.2014, p. 500-504.

Research output: Contribution to journalArticle

Pereira, GR, Lorenzo, PL, Carneiro, GF, Bilodeau-Goeseels, S, Kastelic, JP, Esteller-Vico, A, Lopez-Bejar, M & Liu, I 2014, 'Selection of developmentally competent immature equine oocytes with brilliant cresyl blue stain prior to in vitro maturation with equine growth hormone', Zygote, vol. 22, no. 4, pp. 500-504. https://doi.org/10.1017/S096719941200072X
Pereira, Gabriel R. ; Lorenzo, Pedro L. ; Carneiro, Gustavo F. ; Bilodeau-Goeseels, Sylvie ; Kastelic, John P. ; Esteller-Vico, Alejandro ; Lopez-Bejar, Manel ; Liu, Irwin. / Selection of developmentally competent immature equine oocytes with brilliant cresyl blue stain prior to in vitro maturation with equine growth hormone. In: Zygote. 2014 ; Vol. 22, No. 4. pp. 500-504.
@article{ae5766a8957648288567da3a5906996a,
title = "Selection of developmentally competent immature equine oocytes with brilliant cresyl blue stain prior to in vitro maturation with equine growth hormone",
abstract = "Immature oocytes synthesize a variety of proteins that include the enzyme glucose-6-phosphate dehydrogenase (G6PDH). Brilliant cresyl blue (BCB) is a vital blue dye that assesses intracellular activity of G6PDH, an indirect measure of oocyte maturation. The objective was to evaluate the BCB test as a criterion to assess developmental competence of equine oocytes and to determine if equine growth hormone (eGH) enhanced in vitro maturation (IVM) of equine oocyte. Cumulus-oocytes complexes (COCs) were recovered by aspirating follicles <30 mm in diameter from abattoir-derived ovaries and were evaluated morphologically. Thereafter, COCs were exposed to BCB (26 μM) for 90 min at 39°C and selected based on the colour of their cytoplasm (BCB positive/BCB+ or BCB negative/BCB-). The COCs were allocated as follows: (a) IVM medium; (b) eGH group; (c) BCB-/IVM; (d) BCB+/IVM; (e) BCB-/eGH; and (f) BCB+/eGH. Then, COCs were cultured in vitro for 30 h, at 39°C in a 5{\%}CO2 humidified air atmosphere. Cumulus-free oocytes were incubated in 10 μg/ml of bis-benzamide for 20 min at 39°C and nuclear maturation was evaluated with epifluorescence microscopy. Of the 39 COCs selected morphologically and subjected to BCB staining, 18/39 (46.2{\%}) were classified as BCB+ and 21/39 (53.8{\%}) as BCB- (P > 0.05). Maturation was not affected significantly by BCB classification, but the maturation rate was higher for oocytes that had been exposed to exogenous eGH versus controls (16/28, 57.1{\%} versus 8/26, 30.8{\%}, P < 0.05). In the present study, the BCB test was not useful for predicting competent equine oocytes prior to IVM. However, eGH enhanced equine oocyte maturation in vitro.",
keywords = "Brilliant cresyl blue, Equine growth hormone, Horse, In vitro maturation, Oocyte competence",
author = "Pereira, {Gabriel R.} and Lorenzo, {Pedro L.} and Carneiro, {Gustavo F.} and Sylvie Bilodeau-Goeseels and Kastelic, {John P.} and Alejandro Esteller-Vico and Manel Lopez-Bejar and Irwin Liu",
year = "2014",
month = "1",
day = "1",
doi = "10.1017/S096719941200072X",
language = "English (US)",
volume = "22",
pages = "500--504",
journal = "Zygote",
issn = "0967-1994",
publisher = "Cambridge University Press",
number = "4",

}

TY - JOUR

T1 - Selection of developmentally competent immature equine oocytes with brilliant cresyl blue stain prior to in vitro maturation with equine growth hormone

AU - Pereira, Gabriel R.

AU - Lorenzo, Pedro L.

AU - Carneiro, Gustavo F.

AU - Bilodeau-Goeseels, Sylvie

AU - Kastelic, John P.

AU - Esteller-Vico, Alejandro

AU - Lopez-Bejar, Manel

AU - Liu, Irwin

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Immature oocytes synthesize a variety of proteins that include the enzyme glucose-6-phosphate dehydrogenase (G6PDH). Brilliant cresyl blue (BCB) is a vital blue dye that assesses intracellular activity of G6PDH, an indirect measure of oocyte maturation. The objective was to evaluate the BCB test as a criterion to assess developmental competence of equine oocytes and to determine if equine growth hormone (eGH) enhanced in vitro maturation (IVM) of equine oocyte. Cumulus-oocytes complexes (COCs) were recovered by aspirating follicles <30 mm in diameter from abattoir-derived ovaries and were evaluated morphologically. Thereafter, COCs were exposed to BCB (26 μM) for 90 min at 39°C and selected based on the colour of their cytoplasm (BCB positive/BCB+ or BCB negative/BCB-). The COCs were allocated as follows: (a) IVM medium; (b) eGH group; (c) BCB-/IVM; (d) BCB+/IVM; (e) BCB-/eGH; and (f) BCB+/eGH. Then, COCs were cultured in vitro for 30 h, at 39°C in a 5%CO2 humidified air atmosphere. Cumulus-free oocytes were incubated in 10 μg/ml of bis-benzamide for 20 min at 39°C and nuclear maturation was evaluated with epifluorescence microscopy. Of the 39 COCs selected morphologically and subjected to BCB staining, 18/39 (46.2%) were classified as BCB+ and 21/39 (53.8%) as BCB- (P > 0.05). Maturation was not affected significantly by BCB classification, but the maturation rate was higher for oocytes that had been exposed to exogenous eGH versus controls (16/28, 57.1% versus 8/26, 30.8%, P < 0.05). In the present study, the BCB test was not useful for predicting competent equine oocytes prior to IVM. However, eGH enhanced equine oocyte maturation in vitro.

AB - Immature oocytes synthesize a variety of proteins that include the enzyme glucose-6-phosphate dehydrogenase (G6PDH). Brilliant cresyl blue (BCB) is a vital blue dye that assesses intracellular activity of G6PDH, an indirect measure of oocyte maturation. The objective was to evaluate the BCB test as a criterion to assess developmental competence of equine oocytes and to determine if equine growth hormone (eGH) enhanced in vitro maturation (IVM) of equine oocyte. Cumulus-oocytes complexes (COCs) were recovered by aspirating follicles <30 mm in diameter from abattoir-derived ovaries and were evaluated morphologically. Thereafter, COCs were exposed to BCB (26 μM) for 90 min at 39°C and selected based on the colour of their cytoplasm (BCB positive/BCB+ or BCB negative/BCB-). The COCs were allocated as follows: (a) IVM medium; (b) eGH group; (c) BCB-/IVM; (d) BCB+/IVM; (e) BCB-/eGH; and (f) BCB+/eGH. Then, COCs were cultured in vitro for 30 h, at 39°C in a 5%CO2 humidified air atmosphere. Cumulus-free oocytes were incubated in 10 μg/ml of bis-benzamide for 20 min at 39°C and nuclear maturation was evaluated with epifluorescence microscopy. Of the 39 COCs selected morphologically and subjected to BCB staining, 18/39 (46.2%) were classified as BCB+ and 21/39 (53.8%) as BCB- (P > 0.05). Maturation was not affected significantly by BCB classification, but the maturation rate was higher for oocytes that had been exposed to exogenous eGH versus controls (16/28, 57.1% versus 8/26, 30.8%, P < 0.05). In the present study, the BCB test was not useful for predicting competent equine oocytes prior to IVM. However, eGH enhanced equine oocyte maturation in vitro.

KW - Brilliant cresyl blue

KW - Equine growth hormone

KW - Horse

KW - In vitro maturation

KW - Oocyte competence

UR - http://www.scopus.com/inward/record.url?scp=84910621683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910621683&partnerID=8YFLogxK

U2 - 10.1017/S096719941200072X

DO - 10.1017/S096719941200072X

M3 - Article

C2 - 23369728

AN - SCOPUS:84910621683

VL - 22

SP - 500

EP - 504

JO - Zygote

JF - Zygote

SN - 0967-1994

IS - 4

ER -